Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
san francisco blog main
san francisco top stories
alex azar
avapritinib
blueprint medicines
boston
donald trump
eli lilly
fda
genentech
indiana blog main
indiana top stories
medicare
medullary thyroid cancer
national
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
alirocumab
american patients first
biosimilars
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
capmatinib
center for medicare and medicaid services
clinical trials
craig garthwaite
cstone pharmaceuticals
cvs health
deals
What
blueprint
4
×
drug
4
×
approval
cancer
fda
medicines
plan
prescription
prices
ret
trump
address
administration
afternoon
announced
anticipated
approves
awaited
biopharma
candidate
carries
certain
cheaper
cost
currently
cut
designed
details
drugs
foreign
genetic
house
latest
long
lower
lowering
marketing
meant
medicare
muscle
Language
unset
Current search:
drug
×
biotech
×
blueprint
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
